drugset / Trial / NCT00135642

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

NCT00135642 ↗

Phase 3 Completed 44 enrolled Imperial College London ALK-Abelló A/S · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to assess the effects of grass pollen immunotherapy on symptoms, bronchial hyperresponsiveness and quality of life in seasonal rhinitis and asthma. Hay fever symptoms and medication use, health-related quality of life, and measurements of non-specific bronchial responsiveness were recorded during the study period.

Timeline

Start
1996-02
Primary completion
—
Completion
1998-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alutard SQ Vaccine — Subcutaneous